Consonance Capital

Latest statistics and disclosures from Consonance Capital Management's latest quarterly 13F-HR filing:

Companies in the Consonance Capital Management portfolio as of March 2019 quarter

Company (Ticker) Portfolio Weight Share Count Change in Shares Price
Amarin Corporation (AMRN) 14.40 10.99M +16% 20.76
United Therapeutics Corporation (UTHR) 9.08 1.23M +11% 117.37
Pacira Pharmaceuticals, Inc. 8.77 3.65M 38.06
Uniqure Nv shs 7.48 1.99M +4% 59.65
Myriad Genetics (MYGN) 6.94 3.31M +39% 33.20
Retrophin 5.76 4.03M 22.63
Catalyst Pharmaceutical Partners (CPRX) 5.75 17.88M +90% 5.10
Aerie Pharmaceuticals 5.09 1.70M NEW 47.50
Vanda Pharmaceuticals (VNDA) 4.95 4.26M -8% 18.40
Vericel 4.74 4.29M 17.51
Urogen Pharma 4.10 1.76M +16% 36.94
Oxford Immunotec Global 2.84 2.61M 17.23
Corcept Therapeutics Incorporated (CORT) 2.78 3.75M -39% 11.74
Epizyme 2.72 3.48M NEW 12.39
Omeros Corporation (OMER) 2.33 2.12M NEW 17.37
Kadmon Hldgs Inc Com stock 1.94 11.63M NEW 2.64
Karyopharm Therapeutics 1.90 5.16M +7% 5.84
Aurinia Pharmaceuticals 1.73 4.22M +42125% 6.50
Chemocentryx 1.46 1.67M NEW 13.89
Savara 1.44 3.09M 7.37
Adma Biologics 1.10 4.59M 3.79
Akebia Therapeutics 0.74 1.43M NEW 8.19
Iovance Biotherapeutics 0.68 1.14M NEW 9.51
Biosante Pharmaceuticals 0.64 142943 70.54
Radius Health Inc note 3.000% 9/0 0.47 9.00M 0.83
Immunomedics (IMMU) 0.18 145000 NEW 19.21

Past 13F-HR SEC Filings by Consonance Capital Management

View All Filings